Madrigal Pharmaceuticals (MDGL) PT Raised to $405 at Evercore ISI, ‘well positioned to execute on the launch of Rezdiffra’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Madrigal+Pharmaceuticals+%28MDGL%29+PT+Raised+to+%24405+at+Evercore+ISI%2C+%27well+positioned+to+execute+on+the+launch+of+Rezdiffra%27/22950978.html for the full story.

Leave a Reply

Your email address will not be published. Required fields are marked *